RL388 monoclonal antibodies in human [13,14] and rodent Abstract Galectin-3, a mammalian galaetoside-binding protein, is not expressed in the Jurkat T-lymphoblastoid cell line.[15,16] cells, respectively. CD98 antigen is expressed on most However, Jurkat cells express surface glycoprotein receptors cell lines in culture as well as on monocytic cells. Interestingly, for galectin-3, one of which is shown to be the glycosylated heavy CD98 is also expressed on activated human lymphocytes chain of CD98 (4F2 antigen), a T-cell activation marker, although not on resting T and B lymphocytes. Although preAddition of galectin-3 to Jurkat cells triggers a sustained influx liminary evidence [17] suggests that lymphocytes do not exof extracellular Ca 2+ in a concentration dependent manner. The press galectin-3, we were prompted by these findings to examinduced increase in eytosollc [Ca2+]i is blocked by sugar hapten ine whether lymphocytes bind exogenous lectin. In this report, inhibitors of galectin-3. The galectin-3-induced effect is insensiwe show that exogenous galectin-3 binds to surface glycoprotire to voltage-gated Ca 2+ channel antagonists such as teins, including CD98, of the human lymphoblastoid Jurkat prenylamlne, nifedipine and diltiazem and to pertussis toxin but T-cell line. Furthermore, surface ligation of these cells triggers is inhibited by cholera toxin. The results suggest that galectin-3 released by accessory cells such as macrophages may bind in vivo an increase in intracellular Ca 2+, suggesting that activated to T-cell activation antigens and also participate in Ca 2+ lymphocytes may be responsive to galectin 3 released from signalling, other cell types.